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Abstract
Canine Inflammatory Bowel Disease (IBD) is considered a multifactorial disease caused by
complex interactions between the intestinal immune system, intestinal microbiota and envi-
ronmental factors in genetically susceptible individuals. Although IBD can affect any breed,
German shepherd dogs (GSD) in the UK are at increased risk of developing the disease.
Based on previous evidence, the aim of the present study was to identify single nucleotide
polymorphisms (SNPs), which may confer genetic susceptibility or resistance to IBD using a
genome-wide association study (GWAS). Genomic DNA was extracted from EDTA blood or
saliva samples of 96 cases and 98 controls. Genotyping of cases and controls was performed
on the Canine Illumina HD SNP array and data generated was analyzed using PLINK. Sev-
eral SNPs and regions on chromosomes 7,9,11 and 13 were detected to be associated with
IBD using different SNP-by-SNP association methods and FST windows approach. Search-
ing one Mb up-and down-stream of the most significant SNPs, as identified by single SNP
analysis as well as 200Kb before and after the start and the end position of the associated
regions identified by FST windows approach, we identified 63 genes. Using a combination of
pathways analysis and a list of genes that have been reported to be involved in human IBD,
we identified 16 candidate genes potentially associated with IBD in GSD.
1. Introduction
Inflammatory bowel disease (IBD) is a chronic debilitating disease that affects both humans
and dogs. In dogs, it represents a group of common chronic enteropathies characterized by
persistent or recurrent gastrointestinal signs (GI) and with histological evidence of inflamma-
tion (usually lymphoplasmacytic and/or eosinophilic) in the lamina propria of the small intes-
tine, large intestine or both [1]. Despite recent progress and improvement in the diagnosis of
IBD in dogs, the treatment of this condition remains challenging. IBD is not a curable disease,
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therefore the aim of current treatment protocols is to minimise the severity and frequency of
the clinical signs including vomiting and diarrhoea. In general, treatment protocols include
sequential dietary [2, 3], antibiotic [4,5] and corticosteroid [6] treatment trials. Currently,
treatment with anti-inflammatory medications such as corticosteroid is the mainstay treat-
ment for both human IBD and canine IBD patients [4]. However, the response to treatment is
highly variable, and up to 50% of dogs with IBD that are initially managed with steroids will
develop resistance and/or significant side effects, which ultimately leads to euthanasia in many
dogs [6–8]. Recent advances in the field of molecular genetics in human IBD make it possible
to use the patients’ genetic profile to predict the response to treatment [9, 10]. Similar to
human, understanding the genes involved in canine IBD is predicted to reveal insights into
disease pathogenesis in canine IBD. This could lead to the development of genetic screening
tests for diagnosis and a “personalized medicine” approach, where dogs will be treated with
specifically targeted therapeutics, taking their individual genetic makeup into account.
Although IBD can affect any dog, breed-specific associations and disease phenotypes have
been reported in the literature [11, 12]. In the United Kingdom (UK), German shepherd dogs
are at increased risk of developing the disease [13]. The exact aetiology of IBD in humans as
well as dogs is not well understood, although it is considered to be a multifactorial immune-
mediated disease in both species, resulting from a complex interaction between the intestinal
innate and adaptive immune systems, the intestinal microbiome, and the genetic make-up of a
potentially susceptible individual [14–17].
While recent genome-wide association studies (GWAS), investigating the complex genetic
basis of IBD in humans have resulted in the identification of 163 susceptibility loci [18], the
genetic factors contributing to susceptibility to canine IBD remain largely unknown. Genetic
studies into canine IBD, using a candidate gene approach, have revealed a breed-independent
association with non-synonymous single nucleotide polymorphisms (SNPs) in Toll-like recep-
tor (TLR)-5, a gene encoding an important mucosal pattern recognition receptor (PRR). In
addition, breed-specific SNPs in TLR-4 and nucleotide binding oligomerization domain pro-
tein 2 (NOD-2) were identified in GSD [19–21]. A recent study also reported association
between SNPs in Major histocompatibility class (MHC) II haplotypes and a potentially
increased resistance to IBD in GSD [22]. Despite of these findings, it is believed that similar to
human IBD, canine IBD is a complex polygenic disorder with involvement of several more
genetic factors that remain to be identified.
The development of high-throughput SNP genotyping technologies has facilitated the detection
of genes responsible for complex diseases of the dog. Furthermore, long linkage disequilibrium
within breeds resulting from genetic bottlenecks during domestication of dogs and breed forma-
tion, made the dog population structure suitable for association mapping techniques [23,24].
The aim of the current study was to detect additional genetic factors associated with IBD in
a defined GSD population using GWAS approach. SNP profiles for a total of 190 GSDs were
generated using the Canine Illumina HD SNP array. Using the resulting data set, GWAS was
performed, which resulted in the subsequent identification of additional loci associated with
IBD in GSD, some of them also having been described for human IBD.
2. Materials and methods
2.1. Ethics and welfare statement
All blood samples used in this study were collected in ethylenediaminetetraacetic acid (EDTA)
and were residual material following completion of diagnostic testing, used for research with
informed written owner consent. The use of residual EDTA blood and buccal swab samples
was approved by the RVC Ethics and Welfare Committee (reference number 2013 1210).
Genome-wide association studies of inflammatory bowel disease in German shepherd dogs
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preparation of the manuscript.
Competing interests: We have the following
interests: This study was funded in part by Laboklin
GmBH. There are no patents, products in
development or marketed products to declare. This
does not alter our adherence to all the PLOS ONE
policies on sharing data and materials.
2.2. Study population and genotyping
The case population consisted of 96 GSDs based in the UK, which were diagnosed with IBD at
either the Royal Veterinary College (University of London, Uk), the Small Animal Teaching
Hospital (University of Cambridge, UK), the Animal Health Trust (Newmarket, UK), or three
small animal referral centres including Anderson Moores Veterinary Specialists (Hampshire,
UK), Davies Veterinary Specialists (Hitchin, UK) and Hope Vets (Bovingdon, UK). The case
population was identified using stringent inclusion criteria: all cases have been affected by
chronic gastrointestinal signs (i.e. > 3 weeks duration), including diarrhoea and/or vomiting
and/or anorexia and/or weight loss. Other causes of chronic gastrointestinal disease had been
excluded, by performing routine haematology, serum biochemistry, faecal parasitology and
bacteriology, abdominal ultrasonography, serum ACTH stimulation tests and measurement of
serum canine trypsin-like immunoreactivity concentration (TLI), as described in detail previ-
ously [22]. All dogs had undergone gastrointestinal endoscopic examination for the collection
of mucosal intestinal biopsies. Histological examination of the biopsies had revealed lympho-
plasmacytic and/or eosinophilic infiltration of the lamina propria. None of the cases suffered
from concurrent diseases of known or suspected immune-mediated origin, dermatological
conditions or diseases for which GSD are known to be predisposed for (i.e. anal furunculosis,
atopic dermatitis or superficial keratitis).
The control population included 98 GSDs based in the UK. Animals in this group were
only considered for inclusion in the study if they were older than 8 years of age, therefore
reducing the likelihood to develop IBD later in life. Control dogs were retrospectively pheno-
typed, either by owner or veterinary surgeon telephone contact, to ensure they had neither cur-
rent nor previous history of gastrointestinal signs for a duration of more than 5 consecutive
days and did not suffer from conditions of known or suspected immune-mediated origin.
Residual blood samples stored in EDTA anticoagulant were available from the RVC sample
archive for a total of 69 GSD diagnosed with IBD and 81 breed-matched geriatric controls.
EDTA blood samples were also available for 10 cases that have been seen at the University of
Cambridge (8 cases) and the Animal Health Trust (2 cases). In addition, buccal swab samples
from the other cases and controls for which a residual blood sample was not available were
provided by owners for inclusion in the control population.
Genomic DNA (gDNA) was extracted from blood using the GenElute™ Blood Genomic
DNA Kit (Sigma-Aldrich1, Gillingham, UK) and from saliva samples using the Performa-
gene1 Kit (DNA Genotek Inc, Canada) according to manufacturer’s instructions. Following
extraction, the amount of gDNA in all samples were quantified by nucleic acid fluorescent
staining using a commercial kit and following the manufacturer’s instructions (Quant-iT™
PicoGreen1 dsDNA Kit, Life Technologies, Paisley, UK), samples were normalised to a con-
centration of 20 ng μl-1 and stored at -20˚C until use.
The genotyping of all cases and controls was performed using the Illumina 170K Cani-
neHD1 Beadchip (Illumina, San Diego, CA, USA). All SNPs with call rate<90%, minor allele
frequency< 2%, monomorphic, unmapped to the CanFam3.1 reference sequence
(GCF_000002285.3) and samples with call rate<80% were removed. After quality control, 94
cases, 96 controls and 117K SNPs remained for the final analysis.
To assess presence of population stratification, identity-by-decent and multidimensional
scaling (MDS) analyses were performed using PLINK v1.07 software [25]. A scatter plot for
the first 2 dimensions was produced. Population stratification analysis was also performed on
the dataset with the Admixture software [26], with number of subpopulations (K) that ranging
from 1 to 7. The cross-validation error generated at each K value was used to determine the
Genome-wide association studies of inflammatory bowel disease in German shepherd dogs
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best number of subpopulations across the dataset that is represented by the K with the lowest
cross validation error.
2.3. Genome-wide association study
Association analyses were performed using different approaches: a basic case and control asso-
ciation (chi-square allelic test), a logistic regression and a logistic regression using the C1 and
C2 components previously calculated with the MDS analysis as covariate in PLINK v1.07 soft-
ware. P = -log10(5e-08) was considered as significant association, P = -log10(1e-05) considered
as suggestive association. Genomic inflation factor (λ) and quantile-quantile (Q–Q) plots (S1
Fig) were obtained using the GenABEL software [27].
2.4. Fixation index (Fst) analysis
Association analysis was also performed using FST analysis SNP by SNP and using a sliding
window of 1Mb, with 500Kb of overlapping. FST was calculated SNP by SNP, using the adapted
formula below [23]
Fstk ¼ Nk=Dk
Where k is the SNP marker k, with frequency p1[k], p2[k]
Nk ¼ p1
½kðq2
½k   q1
½kÞ þ p2
½kðq1
½k   q2
½kÞ
Dk ¼ p1
½kq2
½k þ q1
½kp2
½k ¼ Nk þ p1
½kq1
½k þ p2
½kq2
½k
The values can range from 0 (no differences) to 1 (complete different). For the window-
based analysis, the mean FST was calculated across the SNPs included in the window.
The top four SNPs for single SNP and 5 windows for overlapping windows were considered
as the most divergent between case and control groups.
2.5. Identification of potential candidate genes
Gene searching was conducted with a range of ±1 Mb for the SNPs based analyses and ±200Kb
for the regions identified with the windows based analysis. To identify potential candidate
genes associated with IBD in GSDs, pathway analysis was performed using the Enrichr tool,
(http://amp.pharm.mssm.edu/Enrichr) to detect genes involved in pathway that could be
related with the disease. For this analysis, the default statistical tests and corrections for multi-
ple testing to maintain an overall p-values of 0.05 were applied. Moreover, all the genes identi-
fied were compared to a list of genes that has been already stablished for human IBD [18], to
search for common genes. Genes that were detected with each of these two approaches were
considered for the discussion.
3. Results
This study is the first GWAS on GSDs with the aim of investigating genetic factors associated
with IBD. We performed genotyping of 170,000 SNP markers of the entire GSD cohort. The
exclusion of non-informative markers, markers with low call rate and individuals with call
rates <80% resulted in 200 individuals (94 cases, 96 controls) and 117K markers passing QC.
Principal component analysis with PLINK (Fig 1) showed no evidence for population stratifi-
cation within our GSD cohort (n = 190). The admixture analysis showed only two subpopula-
tion that are balanced between cases and controls (Fig 2).
Genome-wide association studies of inflammatory bowel disease in German shepherd dogs
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Results of the identity-by-descend analysis revealed three pairs of individuals with high
Identity-by-descent proportion values (P_HAT> 0.90) in our study population. One sample
of each pair was removed (two were cases and one control) prior to association analysis, result-
ing in 92 cases and 95 controls.
3.1. Association tests
IBD in GSD appears to be associated with SNPs on Chromosomes 11. GWAS of 92 cases ver-
sus 95 controls (total of 187 GSDs), using different statistical approaches, identified a number
Fig 1. Scatter plot for the first 2 dimensions. The x-axis is principal component 1 and y-axis is principal component
2. Green: case, Blue: control.
https://doi.org/10.1371/journal.pone.0200685.g001
Fig 2. Admixture plot of the case-control dataset (showed on the right) using the K with the lowest cross-validation error (showed on the left).
https://doi.org/10.1371/journal.pone.0200685.g002
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of SNPs with high differences on chromosomes 7, 9, 11 and 13. Basic case/control association
analysis (Fig 3A) revealed three SNPs on chromosome 9 and one SNP on chromosome 11
with suggestive association. The strongest association (P = 2.36 × 10−6) identified by basic
Fig 3. Manhattan plots of basic case-control association test (a), logistic regression without covariate (b) and logistic regression with
covariate (c). Suggestive association threshold is indicated with the blue line. SNPs of the logistic analyses with the lowest p-value that
overlapped the basic association study are within red circles.
https://doi.org/10.1371/journal.pone.0200685.g003
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case/control association analysis was for SNP BICF2S23033111 at position 20,056,580 on chro-
mosome 11. A second peak was within a region on chromosome 9 spanning from position
51,531,181 to 51,544,743 bp. In this region, three SNPS (BICF2P812982, BICF2P436494 and
BICF2P753594) were identified, Results are shown in Table 1.
Logistic association approaches were also performed as our trait of interest was binary.
These SNPs were found to have the lowest p-values by both logistic associations with no covar-
iate (Fig 3B and S1 Table) and with covariate (Fig 3C and S2 Table), although they did not
reach the significance threshold (Fig 3B and 3C and S1 and S2 Tables respectively).
Quantile–quantile plots for the three analyses (S1 Fig) showed the relationship between
observed (y-axis) and expected (x-axis) test statistics and visualize the population substructure.
The slight deviation in the upper right tail from the y = x line are suggestive of associations.
Data generally falling on the y = x lines suggests no clear systemic bias. The degree of deviation
from this line is measured by the ?-statistic, where a value close to 1 indicates that the data fol-
lows the normal chi-squared distribution. The logistic with no covariate (Figure B in S1 Fig)
showed the lowest ?, which can be considered as most conservative model. The correction
with population derived covariate (Figure C in S1 Fig) showed a difference in values. However,
in both three cases, big differences were not observed, as the study population is fairly homoge-
nous [28].
3.2. Fixation index (Fst) tests
The FST analyses was carried out SNP by SNP, reported the top 5 most divergent SNPs on chro-
mosomes 9, 11 and 12 (Fig 4 and S3 Table). Anyway, the to 4 SNPs, three on chromosome 9
and 1 on chromosome 11, overlapped those previously identified with the association analyses.
The results of the Fst window-based analysis indicated five main divergent regions between cases
and controls: four on chromosome 7 and one on chromosome 13 with the highest m FST value
(Table 2).
3.2 Candidate genes
The gene searching of the SNPs and windows-based analysis identified 80 genes, 44 detected
with considering the consensus SNPs of the singles SNPs analyses (S4 Table), and 36
Table 1. The most significant SNPs found by basic case/control association analysis.
CHR SNP BP A1 F_A F_U A2 CHISQ P OR
9 BICF2P753594 51531181 C 0,07609 0,2447 G 19,54 9,86E-06 0,2542
9 BICF2P436494 51541093 G 0,07609 0,25 A 20,52 5,91E-06 0,2471
9 BICF2P812982 51544743 G 0,07609 0,2553 A 21,51 3,52E-06 0,2402
11 BICF2S23033111 20056580 C 0,212 0,04787 A 22,28 2,36E-06 5,349
CHR: Chromosome
SNP: SNP ID
BP: Physical position on CanFam3.1
A1: Minor allele name (based on whole sample)
F A: Frequency of this allele in cases
F U: Frequency of this allele in controls
A2: Major allele name
CHISQ: Basic allelic test chi-square
P: Asymptotic p-value for this test
OR:Estimated odds ratio (for A1, i.e. A2 is reference)
https://doi.org/10.1371/journal.pone.0200685.t001
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considering the regions detected with the windows-based Fst analysis (S5 Table). The combi-
nation of pathway association analysis and the literature search to look for genes already found
to be involved in human IBD [18] identified a total of 16 candidate genes potentially associated
with IBD in GSD (Table 3). Among these, a total of 11 genes have been previously reported to
be associated with human IBD, eight of these genes are also involved in pathways such as Cyto-
kines and Inflammatory Response and Glucocorticoid receptor regulations (Table 3 and S6
Table). Genes encoding for cytokines, including Th2 cytokine, IL-4 and IL-13, were amongst
these genes, and were detected by both approaches.
4. Discussion
In the present study, we identified candidate genes on several canine chromosomes that are
potentially associated with IBD in GSD. These genes may have an impact on the immune-
homeostasis in the canine gut, similar as described for the situation in human IBD.
A number of studies have highlighted the role of immunologic mechanisms and in particu-
lar, the involvement of specific cytokine subsets in the pathogenesis of canine IBD. Observa-
tions of increased numbers of immunoglobulin-containing cells and T cells in inflamed tissues
[1, 29–31], upregulated mucosal and luminal expression of nitric oxide metabolites [32,33],
and altered serum concentrations of select acute phase proteins, such as C-reactive protein,
which is a marker of inflammation and tissue injuries, in IBD dogs [34,35], support the
involvement of impaired immunoregulation in pathogenesis of canine IBD.
Our study results suggest a potential involvement of Th2 cytokines in the pathogenesis of
IBD in GSDs, similar as described for ulcerative colitis (UC) in humans. According to the cyto-
kine profile, CD4+ T cells can be divided into major subtypes, with Th1 cells producing mainly
IL-2, IL-12, IFNg, TNFα, favoring the development of a cell-mediated immune response,
Fig 4. Single FST approach result. SNPs with the highest FST value that overlap the basic case/control association test
and logistic association are within red circles.
https://doi.org/10.1371/journal.pone.0200685.g004
Table 2. Regions on chromosome 7 and 13, found by FST windows approach.
chromosome Start End N.Snps mFST
7 4000000 5000000 31 0.0362679
7 3500000 4500000 44 0.0384714
13 2500000 3500000 33 0.038702
7 2500000 3500000 17 0.0403834
7 3000000 4000000 39 0.0408544
Start: start position of the window. End: End position of the window. N.Snps: number of SNPs included in each window. mFST: mean FST value calculated for SNPs
included in each window.
https://doi.org/10.1371/journal.pone.0200685.t002
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whereas Th2 cells mainly produce IL-4, IL-5 and IL-13, which results in the induction of a
humoral immune response [36].
In humans, IL-13, produced by specialized cells such as NK T-cells, was identified as an
important effector cytokine in UC [37], and its release may impair epithelial barrier function
by affecting epithelial apoptosis, tight junctions, and restitution velocity [38]. In addition, lam-
ina propria mononuclear cells (LPMCs) from UC patients have been described to secrete sig-
nificantly higher amounts of IL-13 and IL-5 than LPMCs from CD patients and healthy
controls [37,38]. The IL-13 and IL-5 producing LPMCs bear the NK cell specific markers
CD161 and detect CD1d, providing evidence that the release of these cytokines is due to acti-
vation of NK T-cells [37]. It was also shown that the NK T-cells isolated from UC patients are
cytotoxic for HT-29 epithelial cells, and that this cytotoxicity was enhanced further by addition
of IL-13 [37]. In addition, IL-13 signalling through the IL-13α2 receptor (IL-13Rα) induces
TGF-β1 production and fibrosis [39]. Many functions of IL-13 are shared with the major Th2
cytokine IL-4. Results of studies performed in a murine model of IBD suggest that in T cell
receptor α chain–deficient (TCRα-/-) mice, treatment with anti–IL-4 Ab resulted in a decrease
of Th2 cytokines, and a concomitant increase of IFN-γ, suggesting that not only NK-T cells,
but also CD4+ Th2 T cells play a major immunopathological role in the induction of IBD [40].
A similar finding of the potential involvement of IL-4 in canine IBD was confirmed by Jergens
[41].
It is worth noticing however, that studies in canine IBD revealed contradictory results
regarding the cytokine mRNA expression patterns in intestinal biopsies. German et al. [31]
reported a mixed Th1-Th2 cytokine expression in GSDs with small intestinal enteropathy.
However, this study included only four dogs diagnosed with IBD. In another study, up-
Table 3. Enricher results. Genes found to be enriched in biological processes and/or molecular components that are associated or directly/indirectly involved with
human IBD.
Chromosme
region
gene
symbol
gene name gene start gene end database
7 PTPRC Protein tyrosine phosphatase, receptor type C 4156687 4282147 KEEG
9 TSC1 Tuberous sclerosis 1 51419149 51454668 KEEG
RALGDS Ral guanine nucleotide dissociation stimulator 51308323 51330270 KEEG
COL5A1 Collagen type V alpha 1 chain 50741552 50856744 Wikipathways20016
RAPGEF1 Rap guanine nucleotide exchange factor 1 52450597 52562778 Wikipathways20016
11 IL4 Interleukin-4 20972693 20981541 KEEG; Wikipathways20016; Panther 2016;
NCI-Nature 2016
IL5 Interleukin-5 20825469 20827269 KEEG; Wikipathways20016; Panther 2016;
NCI-Nature 2016
CSF2 Granulocyte-macrophage colony-stimulating factor 20344009 20346959 KEEG; Wikipathways20016
IL13 Interleukin-13 precursor 20958464 20961391 KEEG; Wikipathways20016; Panther 2016;
NCI-Nature 2016
SLC22A4 Solute carrier family 22 member 4 20598888 20644639 KEEG
SLC22A5 Solute carrier family 22 member 5 20659221 20683073 KEEG
IRF1 Interferon regulatory factor 1 20772643 20781207 NCI-Nature 2016
ACSL6 acyl-CoA synthetase long-chain family member 6 20223930 20285138 -
IL3 Interleukin-3 20330480 20332668 -
PDLIM4 PDZ and LIM domain 4 20570752 20587263 -
13 YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein, zeta
2729503 2763613 Wikipathways20016
Genes found already to be associated with human IBD.
https://doi.org/10.1371/journal.pone.0200685.t003
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regulation of IL-2 and TNF-α mRNA, two classic Th1 cytokines, in the colonic mucosa of
dogs with lymphocytic-plasmacytic colitis (LPC) was reported in dogs with large or small
intestinal IBD [42]. Furthermore, no differences in the mRNA expression of IL-2, IL-4, IL-5,
IL-6, IL-10, IL-12, IL-18, IFN-γ, TNF-α and TGF-β was detected between healthy dogs or dogs
with IBD in more recent studies using real-time q-RT-PCR [43,44]. Finally, Jergens et al. [41]
demonstrated expression of a diverse range of pro-inflammatory, anti-inflammatory, and reg-
ulatory cytokines in the intestinal mucosa, which differed between dogs with IBD and clini-
cally healthy dogs. Results of these studies suggested at the time, that a predominant Th1- or
Th2 cytokine mRNA expression in the inflamed mucosa is not a feature of small- or large-
intestinal IBD in dogs [41].
The variations in pattern of cytokine expression observed in these studies might be
explained by different methods for mRNA quantification, including semi-quantitative
RT-PCR [31,41,42] and real-time RT-PCR [43] techniques, the relatively small number of IBD
dogs investigated in each study, and a potential over-representation of GSDs with enteropa-
thies in most studies [31,42,43]. Furthermore, and in contrast to the present study, all of these
studies involved a mixture of dog breeds, which may impact on the results obtained and could
potentially suggest that different cytokine expression patterns are involved in the pathogenesis
of IBD in different breeds. Therefore, to obtain a better insight into pathogenesis of the disease,
the current study has focused on one breed and investigated relatively large number of dogs
with IBD.
The GWAS data obtained in the present study on GSDs are in agreement with results
obtained for UC in humans. Here, IBD is the result of disruption of intestinal immunological
homeostasis, and particularly the alteration of the normal balance that the gut maintains
between inflammatory and regulatory cytokines [45–47]. Interestingly, cytokine analysis in
humans suggests a different pathology of the two main types of IBD. Inflammation associated
with Crohn’s disease (CD) is believed to be driven by Th1 cells, producing IFN-ɣ and IL 2, and
Th17 cells producing IL-17 and IL-22 [48–52]. In contrast, a Th2 cytokine pattern with IL-4
and IL-5 was found to be important in the pathogenesis of UC [50]. Furthermore, there is evi-
dence that impaired regulation of immune responses by regulatory T cells (Treg) play a part in
pathogenesis of human IBD [53]. Recently, these cells also have been characterized in dogs
[54], and a decreased number of Treg cells was seen in the peripheral blood [55] and duodenal
mucosa of dogs with IBD [56,57]. Whether this observation is a result of IBD, leading to the
development of Treg cells that are unable to counteract the inflammatory process in the intes-
tine of dogs with IBD, or a primary result of functional impairment of Tregs in dogs with IBD
needs to be studied further.
In conclusion, based on the data provided within the present study, Th2 cytokines may
have the potential of causing the epithelial cell damage in GSDs with IBD. Targeted re-
sequencing of the genes identified in our study will help to identify causative SNPs and subse-
quent functional analysis of the causal SNPs may reveal insights into mechanisms involved in
pathogenesis of canine IBD.
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